Cargando…
Plectin-1 Targeted AAV Vector for the Molecular Imaging of Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) is highly malignant disease that is the fourth leading cause of cancer-related death in the US. Gene therapy using AAV vectors to selectively deliver genes to PDAC cells is an attractive treatment option for pancreatic cancer. However, most AAV serotypes displ...
Autores principales: | Konkalmatt, Prasad R., Deng, Defeng, Thomas, Stephanie, Wu, Michael T., Logsdon, Craig D., French, Brent A., Kelly, Kimberly A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629297/ https://www.ncbi.nlm.nih.gov/pubmed/23616947 http://dx.doi.org/10.3389/fonc.2013.00084 |
Ejemplares similares
-
Nephron segment-specific gene expression using AAV vectors
por: Asico, Laureano D., et al.
Publicado: (2018) -
Plectin in Cancer: From Biomarker to Therapeutic Target
por: Perez, Samantha M., et al.
Publicado: (2021) -
Plectin-1 Targeted Dual-modality Nanoparticles for Pancreatic Cancer Imaging
por: Chen, Xiao, et al.
Publicado: (2018) -
Tumor-Specific Delivery of Immune Checkpoint Inhibitors by Engineered AAV Vectors
por: Reul, Johanna, et al.
Publicado: (2019) -
Plectin in Health and Disease
por: Wiche, Gerhard
Publicado: (2022)